List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 2121 studies with search of: Lung Diseases, Obstructive
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Procedure: Patient education and disease management
2 Not yet recruiting The Canadian Cohort Obstructive Lung Disease
Conditions: COPD;   Chronic Obstructive Pulmonary Disease
Intervention:
3 Not yet recruiting A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases;   Respiratory Tract Diseases;   Chronic Obstructive Airway Disease;   COPD
Interventions: Drug: placebo;   Drug: active comparator;   Drug: PF-03635659
4 Active, not recruiting Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General Practice
Condition: Lung Diseases, Obstructive
Interventions: Behavioral: an integrated self-management education program;   Behavioral: regular practice nurse review;   Behavioral: care at initiative of the patient (usual GP care)
5 Not yet recruiting A Study To Investigate The Safety, Toleration And Efficacy PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases;   Lung Diseases, Obstructive
Interventions: Drug: PF-00610355;   Drug: PF - 00610355;   Drug: PF- 00610355;   Drug: Placebo;   Drug: Salmeterol
6 Active, not recruiting PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Pulmonary Emphysema;   Chronic Bronchitis
Interventions: Drug: PROCHYMAL™;   Drug: Placebo
7 Enrolling by invitation Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Aclidinium bromide
8 Recruiting Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Cyclosporine
9 Recruiting To Assess the Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide at Two Dose Levels in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe, Stable COPD
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: aclidinium bromide
10 Completed The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol 300 µg delivered via SDDPI;   Drug: Placebo to indacaterol delivered via SDDPI
11 Recruiting To Assess the Long-term Safety, Efficacy and Tolerability of Inhaled Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
12 Recruiting Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Emphysema;   Bronchitis, Chronic
Intervention:
13 Not yet recruiting Palliation of Dyspnea in Advanced Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Opioid (morphine sulphate) in low dose
14 Recruiting A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Cardiovascular Disease;   Chronic Bronchitis;   Chronic Obstructive Pulmonary Disease (COPD);   CV Risk;   Emphysema;   Smoking
Interventions: Drug: ADVAIR DISKUS™ 250/50mcg;   Other: Placebo
15 Recruiting Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases;   Lung Diseases, Obstructive
Intervention:
16 Completed Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive
Interventions: Behavioral: Lifestyle Activity Program;   Behavioral: Exercise Program
17 Active, not recruiting Evaluate Safety of T/I on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Conditions: Diabetic Type 1 With Obstructive Pulmonary Disease;   Diabetic Type 2 With Obstructive Pulmonary Disease;   Asthma;   COPD;   Type 1 Diabetes;   Type 2 Diabetes
Interventions: Drug: Technosphere Insulin;   Drug: Usual Care
18 Recruiting Portable Monitoring Device for the Diagnosis of Obstructive Sleep Apnea Syndrome(OSAS) in Patients With Chronic Obstructive Pulmonary Disease(COPD)
Conditions: Chronic Obstructive Pulmonary Disease;   Obstructive Sleep Apnea Syndrome
Intervention: Other: Polysomnography
19 Recruiting Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Fluticasone propionate/salmeterol combination product;   Drug: Salmeterol;   Drug: Placebo
20 Completed Sildenafil for Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Emphysema
Intervention: Drug: sildenafil citrate

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services